The effect of ramatroban on cytokine and thrombotic storms in Covid-19

Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath

(2022) Kate C. Chiang et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Favipiravir in SARS-CoV-2 infection: Is it Worthwhile?

(2022) Gaber El-Saber Batiha et al.   COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING

A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19

(2022) Gomaa Mostafa-Hedeab et al.   INFLAMMOPHARMACOLOGY

Treatment of COVID-19 Pneumonia and Acute Respiratory Distress With Ramatroban, a Thromboxane A2 and Prostaglandin D2 Receptor Antagonist: A Four-Patient Case Series Report

(2022) Martin L. Ogletree et al.   Frontiers in Pharmacology

Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal

(2022) Gaber El-Saber Batiha et al.   INFLAMMOPHARMACOLOGY

Platelets amplify endotheliopathy in COVID-19

(2021) Tessa J. Barrett et al.   Science Advances

Indomethacin: an exploratory study of antiviral mechanism and host-pathogen interaction in COVID-19

(2021) Nishant Shekhar et al.   Expert Review of Anti-Infective Therapy

Is a “Cytokine Storm” Relevant to COVID-19?

(2020) Pratik Sinha et al.   JAMA Internal Medicine

Prostaglandin D2 as a mediator of lymphopenia and a therapeutic target in COVID-19 disease

(2020) Ajay Gupta et al.   MEDICAL HYPOTHESES

Prostaglandins in Marine Organisms: A Review

(2019) Federica Di Costanzo et al.   Marine Drugs